Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Mink Brook Asset Management LLC, an investment manager holding a 10% stake in DLH Holdings Corp. (NASDAQ: DLHC), recently executed two separate acquisitions of the company's common stock. The transactions, totaling $51,083, were completed over two consecutive days in July 2026. This buying activity occurs while DLHC trades near its 52-week low of $…
Hershey Trust Co, the entity controlling the Milton Hershey School Trust, has executed a significant divestiture of The Hershey Company (NASDAQ:HSY) equity, selling 19,960 shares over two days in July 2026. This transaction occurs against a backdrop of mixed analyst sentiment, with Moody's affirming a stable outlook based on margin expansion while …
Chen Yun-Lung, Ambarella Inc.'s Vice President of Business Development and Marketing, executed a sale of 5,958 ordinary shares on July 9, 2026. The transaction, valued at $468,656 based on a $78.66 per-share price, was disclosed in an SEC Form 4 filed on July 10, 2026. Following the sale, Chen retains direct ownership of 60,557 shares. This insider…
Daniel Timothy Hudson, a director at Hallador Energy Co (NASDAQ:HNRG), executed a purchase of 5,000 shares on July 9, 2026, totaling $82,912. The acquisition occurred at a price range of $16.565 to $16.60 per share. Following this transaction, Hudson directly holds 20,000 shares of the company's common stock. This insider activity aligns with marke…
Control Empresarial de Capitales S.A. de C.V., a key shareholder in PBF Energy Inc. (NYSE:PBF), has reported the sale of 650,000 Class A Common Shares over two days in early July 2026. The transactions, valued at approximately $34.23 million, occurred as PBF Energy's stock approached its 52-week high of $53.55, marking a significant 97.7% gain over…
Datadog, Inc. (NASDAQ:DDOG) Chief Technology Officer Alexis Le-Quoc executed a significant divestment of company shares on July 8, 2026, selling 53,912 Class A Common Stock shares. The transaction, valued at approximately $13,868,383, was conducted under a pre-arranged 10b5-1 trading plan established on June 13, 2025. This sale occurs as Datadog's …
Olesen Value Fund L.P., a major stakeholder in Solitron Devices Inc. (NASDAQ:SODI), executed a divestment of common stock valued at $361,181. The transactions took place on July 8 and July 10, 2026, reducing the fund's direct and indirect holdings in the semiconductor and related devices manufacturer. This sale occurs after a significant price appr…
Nuvalent, Inc. Chief Scientific Officer Henry E. Pelish sold 2,111 shares of the company's Class A Common Stock on July 9, 2026, generating $261,362 from the transaction. The sale was conducted under a Rule 10b5-1 plan established in December 2023, a mechanism typically used to manage tax obligations tied to equity vesting. Following the transactio…
Joseph Sanborn, serving as both Chief Financial Officer and Chief Administrative Officer at EverQuote, Inc. (NASDAQ: EVER), has executed a transaction to sell 6,667 shares of the company's Class A Common Stock. The sale, which generated proceeds totaling $164,208, was conducted on July 8, 2026. The transaction was facilitated through a Rule 10b5-1 …
Tracy G. Smith, Optical Cable Corp (NASDAQ:OCC) Executive Vice President and Chief Financial Officer, executed a series of stock sales totaling $284,189 across two distinct dates in late June and early July 2026. The transactions occur against a backdrop of recent corporate developments, including a significant fiscal second-quarter 2026 earnings t…
Christopher Van Tuyl, Chief Legal Officer at Immunovant, Inc. (NASDAQ:IMVT), executed a series of mandatory stock sales on July 8, 2026, to satisfy tax withholding requirements associated with restricted stock unit settlements. The transactions, totaling $47,702, involved the liquidation of 1,206 shares at prices closely tracking the stock's curren…
Jay S Stout, Chief Technology Officer at Immunovant, Inc., executed a mandatory sale of 3,487 shares on July 8, 2026, to satisfy tax withholding requirements tied to vesting restricted stock units. The transaction occurred as Immunovant's equity approached its 52-week peak, following a significant 135% annual gain. While the sale reduces direct own…
Tempus AI, Inc. (NASDAQ: TEM) CEO of Data, Ryan Fukushima, executed a $1.91 million sale of Class A Common Stock through his spouse on July 8, 2026, as part of a Rule 10b5-1 trading plan established in March 2025. The transaction involved 33,284 shares sold at weighted average prices between $56.80 and $59.47. This divestment follows a period of si…
JFrog Ltd (NASDAQ:FROG) Chief Executive Officer Shlomi Ben Haim executed a sale of 15,000 ordinary shares on July 8, 2026, generating approximately $1,415,525 in proceeds. The transaction was facilitated through a Rule 10b5-1 trading plan established earlier in the year. This sale follows a substantial 135% surge in JFrog's share price over the pas…
Immunovant Inc. (NASDAQ: IMVT) Chief Operating Officer Melanie Gloria executed a series of share sales totaling $80,531 on July 8, 2026. The transactions, driven by mandatory tax withholding requirements for vesting restricted stock units, occurred as the company's stock trades near its 52-week high. This executive activity unfolds against a backdr…
Ryan Cohlhepp, President and COO of Bicara Therapeutics Inc. (NASDAQ: BCAX), executed a series of stock sales totaling approximately $833,129 under a pre-arranged trading plan. The transactions, which followed the exercise of stock options, occurred on July 8 and July 9, 2026, as shares traded near their 52-week high. Concurrently, the biotech firm…
Bicara Therapeutics Inc. (NASDAQ:BCAX) Chief Financial Officer Hyep Ivan completed a significant stock sale on July 8, 2026, while simultaneously acquiring shares through option exercises. The transaction coincides with the company's ongoing clinical development of ficerafusp alfa for head and neck and colorectal cancers, alongside sustained analys…
Powell Industries Inc. (NASDAQ:POWL) President and Chief Executive Officer Brett Cope sold 4,440 shares of the company's common stock on July 9, 2026, realizing approximately $1,072,482 from the transaction. The sale was executed at a price of $241.55 per share pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2025. This transaction oc…
Kelly E. Garcia, Domino's Pizza Inc.'s Executive Vice President and Chief Technology & Data Officer, executed a significant equity transaction on July 9, 2026, selling 487 shares of the company's common stock. The sale, totaling $144,643, was conducted under a Rule 10b5-1 trading plan adopted in May 2025. This disposition followed the same-day exer…
Asaf Silberstein, Executive Vice President and Chief Operating Officer at Semtech Corp (NASDAQ:SMTC), executed a sale of company common stock valued at $1,086,318 on July 8, 2026. The transactions, processed through a Family Trust, involved 8,500 shares traded between $124.1895 and $129.9426 per share. These sales were conducted under a Rule 10b5-1…
MetLife Investment Management, LLC has executed a significant acquisition of debt securities issued by Angel Oak Financial Strategies Income Term Trust (NYSE:FINS). Acting as an investment manager for its clients, MetLife acquired 40,000,000 units of the trust's 5.364% Series C Senior Unsecured Notes due July 8, 2030. The transaction, finalized on …
Gary C. Bhojwani, a director at Hormel Foods Corp. (NASDAQ:HRL), executed a significant share sale on July 8, 2026, totaling $495,158. This transaction follows the company's recent second-quarter fiscal 2026 earnings report, which exceeded analyst expectations for both earnings per share and revenue. The move occurs as Hormel Foods continues to adj…
Tappan Moore III, Chief Operating Officer of Mama’s Creations, Inc. (NASDAQ:MAMA), sold 472 shares on July 8, 2026, for $8,801 at $18.648 per share to cover tax withholding on vested restricted stock units. Post-sale, he holds 12,869 shares. The company recently reported Q1 FY2027 earnings of $0.05 per share and $52.8 million in revenue, beating es…
William Lewis, Chair and Chief Executive Officer of INSMED Inc. (NASDAQ:INSM), executed a series of transactions on July 9, 2026, involving the sale of company shares and the exercise of stock options. The transactions were conducted under a Rule 10b5-1 trading plan established in September 2025. Concurrently, Insmed has announced key leadership ap…
United Therapeutics Corp (NASDAQ:UTHR) director Jan Malcolm sold 325 shares of common stock on July 10, 2026, for a total value of $178,941. The transaction was executed under a pre-arranged 10b5-1 plan established in September 2025. This sale comes amid significant corporate developments, including FDA approval for the LungFX device and positive p…
